COMMONWEALTH EQUITY SERVICES, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in FULC

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$309,024

-$143,376 QoQ

Shares Held

40,290

+0.7% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 168 holders

Holding Since

Dec 2023

10 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,232,394 across 120 Biotechnology names. FULC ranks #51 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$309,024	40,290	+0.7%	Shares	Sole	2026-04-27
2025-12-31	$452,400	40,000	-52.1%	Shares	Sole	2026-02-12
2025-09-30	$767,537	83,428	0.0%	Shares	Sole	2025-10-22
2025-06-30	$573,984	83,428	0.0%	Shares	Sole	2025-08-06
2025-03-31	$240,272	83,428	0.0%	Shares	Sole	2025-05-09
2024-12-31	$392,111	83,428	-1.2%	Shares	Sole	2025-02-10
2024-09-30	$301,407	84,428	0.0%	Shares	Sole	2024-10-18
2024-06-30	$523,453	84,428	+1.2%	Shares	Sole	2024-07-31
2024-03-31	$787,560	83,428	-13.5%	Shares	Sole	2024-04-29
2023-12-31	$650,889	96,428	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.